Key result
Vascular robustness correlated linearly with calendar age in individuals with chronic conditions (p<0.01) and history of cardiovascular events (p<0.0001), but not in apparently healthy individuals.
Why the study?
Does vascular robustness correlate with calendar age differently across cardiovascular risk strata?
Cohort (n=372)
Does vascular robustness correlate with calendar age differently across cardiovascular risk strata?
Vascular robustness, measured non-invasively, declines significantly with age in individuals with cardiovascular risk factors or prior events, but not in healthy individuals, suggesting its potential as a biomarker for premature CVD risk.
Answers are grounded in this paper and cite their sources.
May support vascular assessment in at-risk patients; hypothesis-generating and requires prospective validation before adoption.
Undetected high risk for premature death of cardiovascular disease (CVD) among individuals with low-to-moderate risk factor scores is an acknowledged obstacle to CVD prevention. The vasculature's functional robustness against risk factor derailment may serve as a novel discriminator of mortality risk under similar risk factor loads. To test this assumption, we hypothesized that the expected inverse robustness-mortality association is verifiable as a significant trend along the age spectrum of risk factor-challenged cohorts. This is a retrospective cohort study of 372 adults (mean age 56.1 years, range 21–92; 45% female) with a variety of CV risk factors. An arterial model (VascAssist 2, iSYMED GmbH, Germany) was used to derive global parameters of arterial function from non-invasively acquired pulse pressure waves. Participants were stratified by health status: apparently healthy (AH; n = 221); with hypertension and/or hypercholesterolemia (CC; n = 61); with history of CV event(s) (CVE; n = 90). Multivariate linear regression was used to derive a robustness score which was calibrated against the CVD mortality hazard rate of a sub-cohort of the LURIC study (n = 1369; mean age 59.1 years, range 20–75; 37% female). Robustness correlated linearly with calendar age in CC (F(1, 59) = 10.42; p < 0.01) and CVE (F(1, 88) = 40.34; p < 0.0001) but not in the AH strata, supporting the hypothesis of preferential elimination of less robust individuals along the aging trajectory under risk factor challenges. Vascular robustness may serve as a biomarker of vulnerability to CVD risk factor challenges, prognosticating otherwise undetectable elevated risk for premature CVD mortality.
No takes yet. Share an insight, caveat, or question.
Kraushaar et al. (2018) conducted a cohort in Cardiovascular risk (n=372). Vascular robustness score (delta_age) vs. Apparently healthy individuals was evaluated on Linear correlation between vascular robustness and calendar age in the cardiovascular endpoint (CVE) group (b = -0.37, p=<0.0001). Vascular robustness correlated linearly with calendar age in individuals with chronic conditions (p<0.01) and history of cardiovascular events (p<0.0001), but not in apparently healthy individuals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: